Ampio Pharmaceuticals Inc (AMPE)
0.92
+0.10
(+12.20%)
USD |
NYAM |
Mar 28, 16:00
0.9272
+0.01
(+0.78%)
After-Hours: 20:00
Ampio Pharmaceuticals Free Cash Flow: -10.55M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2023 | -10.55M |
June 30, 2023 | -15.94M |
March 31, 2023 | -18.48M |
December 31, 2022 | -21.13M |
September 30, 2022 | -20.54M |
June 30, 2022 | -18.50M |
March 31, 2022 | -14.89M |
December 31, 2021 | -14.19M |
September 30, 2021 | -13.38M |
June 30, 2021 | -12.20M |
March 31, 2021 | -14.47M |
December 31, 2020 | -14.79M |
September 30, 2020 | -16.66M |
June 30, 2020 | -18.64M |
March 31, 2020 | -17.51M |
December 31, 2019 | -15.40M |
September 30, 2019 | -13.05M |
June 30, 2019 | -11.57M |
March 31, 2019 | -11.36M |
December 31, 2018 | -12.70M |
September 30, 2018 | -12.91M |
June 30, 2018 | -12.80M |
March 31, 2018 | -12.63M |
December 31, 2017 | -11.48M |
September 30, 2017 | -11.45M |
Date | Value |
---|---|
June 30, 2017 | -10.80M |
March 31, 2017 | -12.38M |
December 31, 2016 | -14.62M |
September 30, 2016 | -19.81M |
June 30, 2016 | -23.59M |
March 31, 2016 | -24.39M |
December 31, 2015 | -26.55M |
September 30, 2015 | -25.30M |
June 30, 2015 | -27.81M |
March 31, 2015 | -34.93M |
December 31, 2014 | -39.41M |
September 30, 2014 | -38.93M |
June 30, 2014 | -35.54M |
March 31, 2014 | -28.09M |
December 31, 2013 | -20.77M |
September 30, 2013 | -17.34M |
June 30, 2013 | -13.85M |
March 31, 2013 | -10.82M |
December 31, 2012 | -9.715M |
September 30, 2012 | -11.25M |
June 30, 2012 | -10.92M |
March 31, 2012 | -10.54M |
December 31, 2011 | -9.216M |
September 30, 2011 | -5.825M |
June 30, 2011 | -4.884M |
Free Cash Flow Range, Past 5 Years
-21.13M
Minimum
Dec 2022
-10.55M
Maximum
Sep 2023
-15.43M
Average
-14.89M
Median
Mar 2022
Free Cash Flow Benchmarks
Cyclacel Pharmaceuticals Inc | -16.12M |
Seelos Therapeutics Inc | -23.91M |
Aptevo Therapeutics Inc | -11.73M |
Cingulate Inc | -16.86M |
Kineta Inc | -16.21M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.555M |
Free Cash Flow Per Share (Quarterly) | -0.6902 |
Free Cash Flow Yield | -1.50K% |